Newswire (Published: Monday, March 27, 2017, Received: Thursday, March 23, 2017, 11:57:05 PM CDT)

Word Count: 391

Findings from Prostate Cancer Foundation in the Area of Prostate Cancer Reported (Meeting Report From the Prostate Cancer Foundation Scientific Working Group on Radium-223)

By a News Reporter-Staff News Editor at Clinical Trials Week -- Fresh data on Oncology - Prostate Cancer are presented in a new report. According to news reporting originating in Santa Monica, California, by NewsRx journalists, research stated, "The Prostate Cancer Foundation (PCF) convened a Scientific Working Group Meeting on Radium-223 on September 8, 2016, at The Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center. The meeting was attended by 18 investigators with expertise in radium-223, bone biology, molecular imaging, biomarkers, and prostate cancer clinical trials."

The news reporters obtained a quote from the research from Prostate Cancer Foundation, "The goal of this meeting was to discuss the known and unknown surroundings the therapeutic effects of the bone targeting agent radium-223, in bone metastatic prostate cancer therapy, and to outline the most critical studies needed to improve the clinical use of this agent. Three major topic areas were discussed: (1) the basic science of radium; (2) immuno-adjuvant properties of radium therapy; and (3) high impact clinical trials and correlative science."

According to the news reporters, the research concluded: "This article reviews the major topics discussed at the meeting for the purpose of accelerating studies that will improve the use of radium-223 in the treatment of prostate cancer patients."

For more information on this research see: Meeting Report From the Prostate Cancer Foundation Scientific Working Group on Radium-223. Prostate, 2017;77(3):245-254. Prostate can be contacted at: Wiley-Blackwell, 111 River St, Hoboken 07030-5774, NJ, USA. (Wiley-Blackwell -; Prostate -

Our news correspondents report that additional information may be obtained by contacting H.R. Soule, Prostate Canc Fdn, Santa Monica, CA 90401, United States. Additional authors for this research include M. Morris and H.R. Soule (see also Oncology - Prostate Cancer).

Keywords for this news article include: Santa Monica, California, United States, North and Central America, Clinical Trials and Studies, Alkaline Earth Metals, Radioactive Elements, Prostatic Neoplasms, Clinical Research, Prostate Cancer, Bone Research, Oncology, Radium, Prostate Cancer Foundation.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC


Memorial Sloan-Kettering Cancer Center


Central America
North America
United States
Santa Monica


Science and Technology
      Scientific Research
Health and Wellness
      Medical Conditions and Diseases
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
      Treatments and Therapies